Raal FJ - Search Results

1

Evinacumab for Homozygous Familial Hypercholesterolemia.

Raal FJ, Rosenson RS, Reeskamp LF, Hovingh GK, Kastelein JJP, Rubba P, Ali S, Banerjee P, Chan KC, Gipe DA, Khilla N, Pordy R, Weinreich DM, Yancopoulos GD, Zhang Y, Gaudet D; ELIPSE HoFH Investigators. Raal FJ, et al. N Engl J Med. 2020 Aug 20;383(8):711-720. doi: 10.1056/NEJMoa2004215. N Engl J Med. 2020. PMID: 32813947 Clinical Trial.

2

Microalbuminuria is not associated with cardiovascular disease in patients with homozygous familial hypercholesterolaemia.

Zouvanis M, Raal FJ, Joffe BI, Seftel HC. Zouvanis M, et al. Among authors: raal fj. Atherosclerosis. 1995 Mar;113(2):289-92. doi: 10.1016/0021-9150(94)05443-m. Atherosclerosis. 1995. PMID: 7605367

3

Lack of effect of high dose vitamin E on xanthoma regression in homozygous familial hypercholesterolaemia.

Raal FJ, Areias AJ, Pilcher GJ, Joffe BI, Seftel HC. Raal FJ, et al. Atherosclerosis. 1994 Jun;107(2):213-9. doi: 10.1016/0021-9150(94)90022-1. Atherosclerosis. 1994. PMID: 7980695

4

Expanded-dose simvastatin is effective in homozygous familial hypercholesterolaemia.

Raal FJ, Pilcher GJ, Illingworth DR, Pappu AS, Stein EA, Laskarzewski P, Mitchel YB, Melino MR. Raal FJ, et al. Atherosclerosis. 1997 Dec;135(2):249-56. doi: 10.1016/s0021-9150(97)00168-8. Atherosclerosis. 1997. PMID: 9430375 Clinical Trial.

5

Efficacy of vitamin E compared with either simvastatin or atorvastatin in preventing the progression of atherosclerosis in homozygous familial hypercholesterolemia.

Raal FJ, Pilcher GJ, Veller MG, Kotze MJ, Joffe BI. Raal FJ, et al. Am J Cardiol. 1999 Dec 1;84(11):1344-6, A7. doi: 10.1016/s0002-9149(99)00570-6. Am J Cardiol. 1999. PMID: 10614803

6

Inhibition of cholesterol synthesis by atorvastatin in homozygous familial hypercholesterolaemia.

Raal FJ, Pappu AS, Illingworth DR, Pilcher GJ, Marais AD, Firth JC, Kotze MJ, Heinonen TM, Black DM. Raal FJ, et al. Atherosclerosis. 2000 Jun;150(2):421-8. doi: 10.1016/s0021-9150(99)00435-9. Atherosclerosis. 2000. PMID: 10856535 Clinical Trial.

7

Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia.

Raal FJ, Marais AD, Klepack E, Lovalvo J, McLain R, Heinonen T. Raal FJ, et al. Atherosclerosis. 2003 Dec;171(2):273-9. doi: 10.1016/j.atherosclerosis.2003.07.011. Atherosclerosis. 2003. PMID: 14644397 Clinical Trial.

8

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial.

Raal FJ, Santos RD, Blom DJ, Marais AD, Charng MJ, Cromwell WC, Lachmann RH, Gaudet D, Tan JL, Chasan-Taber S, Tribble DL, Flaim JD, Crooke ST. Raal FJ, et al. Lancet. 2010 Mar 20;375(9719):998-1006. doi: 10.1016/S0140-6736(10)60284-X. Lancet. 2010. PMID: 20227758 Clinical Trial.

9

Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy.

Raal FJ, Pilcher GJ, Panz VR, van Deventer HE, Brice BC, Blom DJ, Marais AD. Raal FJ, et al. Circulation. 2011 Nov 15;124(20):2202-7. doi: 10.1161/CIRCULATIONAHA.111.042523. Epub 2011 Oct 10. Circulation. 2011. PMID: 21986285

10

Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment.

Raal FJ, Santos RD. Raal FJ, et al. Atherosclerosis. 2012 Aug;223(2):262-8. doi: 10.1016/j.atherosclerosis.2012.02.019. Epub 2012 Feb 16. Atherosclerosis. 2012. PMID: 22398274 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

219 results

Search Page